Next Generation Sequencing and Clinical Outcomes of Lung Adenocarcinomas Treated With Stereotactic Body Radiation Therapy
Richard J. Cassidy(Florida Cancer Specialists & Research Institute), Kristin Higgins(Emory University), Taofeek K. Owonikoko(UPMC Hillman Cancer Center), Joseph W. Shelton(Emory University), Gabriel Sica(Emory University), Pretesh Patel(Emory University), Walter J. Curran(Piedmont Cancer Institute), Charles E. Hill(Emory University), Michael R. Rossi(Sema4 (United States)), C. Escott(Emory University), Seth Force(Emory Healthcare), X. Zhang(Emory University), Félix G. Fernández(Emory University), Conor Steuer(Emory University), Madhusmita Behera(National Institutes of Health), Rathi N. Pillai(Emory University), S.S. Ramalingam(Emory University)
International Journal of Radiation Oncology*Biology*Physics
September 23, 2017
Cited by 0
Related Papers
Genomic Classification of Cutaneous Melanoma
|Cell|2015|3.3k
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
|The Lancet|2004|2.4k
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
|Journal of Clinical Oncology|2013|1.1k